For example, a large research pooling 19 early-stage BC studies revealed that although PIK3CA mutations were associated with better OS in a univariate analysis, this relationship was no longer significant after correction via multivariate analysis, and prognosis was not significantly different between patients carrying mutations in the helical versus kinase domain (Zardavas, et al. 2018). Here, PIK3CA is linked to breast cancer.